Displaying 1 - 6 of 6
March 19, 2014
The number and complexity of clinical laboratory tests is rapidly expanding, presenting primary care physicians with challenges in accurately, efficiently, and safely ordering and interpreting diagnostic tests.
Targeted Crizotinib Therapy in People with Lung Cancer – Informing an International Debate on the Cost of Extending Life
July 22, 2013
Recent advances in the treatment of lung cancer hope to stem the tide of this deadly disease, which, in 2009, according to the Centers for Disease Control and Prevention (CDC), killed over 158,000 people; an additional 205,000 were diagnosed.
July 1, 2011
Over an 18-month period, Altarum provided Lean training and technical assistance to FQHC staff members, enabling them to analyze complex procedures and interactions, identify root causes of problems, and test changes and solutions.
Guidelines for Human Epidermal Growth Factor Receptor 2 Testing: Biologic and Methodologic Considerations
March 10, 2009
The goal of this review is to systematically address a number of issues raised in the American Society of Clinical Oncology–College of American Pathologists (ASCO-CAP) guidelines on testing for the human epidermal growth factor receptor 2 (HER-2) alteration
In partnership with the Maryland Health Care Commission (MHCC), Altarum developed a new PROMETHEUS report to power a consumer-friendly transparency dashboard that displays cost and quality information at facilities where a significant number of Maryland residents receive care.